What does APOTHEEK SMETS do?

APOTHEEK SMETS is a pharmacy in Herent. Private Limited, started on 22 October 2002, 1 establishment.

What is the address of APOTHEEK SMETS?

The registered office of APOTHEEK SMETS is located at Wilselsesteenweg 10, 3020 Herent.

Is APOTHEEK SMETS still active?

Yes. According to the CBE (30 October 2026) APOTHEEK SMETS is active, legal situation “Normale toestand”, started on 22 October 2002.

Is APOTHEEK SMETS registered on Peppol?

Yes, APOTHEEK SMETS is registered on the Peppol network with ID 0208:0478682429.

What is the enterprise number of APOTHEEK SMETS?

The enterprise number of APOTHEEK SMETS is BE0478682429.

When was APOTHEEK SMETS founded?

APOTHEEK SMETS was founded on 22 October 2002.

Who are the directors of APOTHEEK SMETS?

According to the 2025 annual accounts, the directors of APOTHEEK SMETS are: Sofimax BV.

Is APOTHEEK SMETS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 22 October 2002; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did APOTHEEK SMETS make in 2025?

APOTHEEK SMETS posted a profit after taxes of € 114,404 in financial year 2025.

What is the revenue of APOTHEEK SMETS?

As a small company, APOTHEEK SMETS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 343,380.

How much does an employee at APOTHEEK SMETS earn?

The average wage cost per full-time employee at APOTHEEK SMETS was € 82,100 in 2025: staff costs of € 131,318 for 1.6 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does APOTHEEK SMETS have?

According to the 2025 annual accounts, APOTHEEK SMETS has 1.6 full-time equivalents (FTE).

APOTHEEK SMETS (Private Limited) - Herent - BE0478682429

Dossier APOTHEEK SMETS, printed on 30 October 2026 from databakkes.be/en/0478682429/apotheek-smets. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

APOTHEEK SMETS from Herent, company number BE0478682429, closed financial year 2025 with a result of € 114,404 after tax. For that financial year APOTHEEK SMETS recorded a gross margin of € 343,380 and equity of € 420,292. Compared with financial year 2024, the result moved from € 76,888 to € 114,404. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on May 28, 2026.

What it is worth Growing

€ 420,292

▲ 12% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 114,404

▲ 49% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 89,126

▲ 292% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 70,000 paid out

61 % of the profit went to the shareholders, mostly to SOFIMAX (99 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

1.6

▲ 0.2 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 131,318

▲ 10% vs 2024

€ 82,100 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt ≈ 12 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 778,638

▼ 6% vs 2024

€ 53,447 is repaid this year. At this pace the long-term loan is gone in ≈ 12 years.

Owed to suppliers

€ 151,630

▲ 97% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 15,418

▲ 2% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 297,373 Gross margin 2022: € 297,373 First fiscal year in the series	€ 293,889 Gross margin 2023: € 293,889 ▼ 1% vs 2022 (€ 297,373) Unfavourable step	€ 285,244 Gross margin 2024: € 285,244 ▼ 3% vs 2023 (€ 293,889) Unfavourable step	€ 343,380 Gross margin 2025: € 343,380 ▲ 20% vs 2024 (€ 285,244) Favourable step	▲ 20%
Profit after taxes	€ 88,726 Profit after taxes 2022: € 88,726 First fiscal year in the series	€ 97,082 Profit after taxes 2023: € 97,082 ▲ 9% vs 2022 (€ 88,726) Favourable step	€ 76,888 Profit after taxes 2024: € 76,888 ▼ 21% vs 2023 (€ 97,082) Unfavourable step	€ 114,404 Profit after taxes 2025: € 114,404 ▲ 49% vs 2024 (€ 76,888) Favourable step	▲ 49%
Equity	€ 336,919 Equity 2022: € 336,919 First fiscal year in the series	€ 359,001 Equity 2023: € 359,001 ▲ 7% vs 2022 (€ 336,919) Favourable step	€ 375,889 Equity 2024: € 375,889 ▲ 5% vs 2023 (€ 359,001) Favourable step	€ 420,292 Equity 2025: € 420,292 ▲ 12% vs 2024 (€ 375,889) Favourable step	▲ 12%
Total debts	€ 1,151,444 Total debts 2022: € 1,151,444 First fiscal year in the series	€ 1,073,562 Total debts 2023: € 1,073,562 ▼ 7% vs 2022 (€ 1,151,444) Favourable step	€ 991,291 Total debts 2024: € 991,291 ▼ 8% vs 2023 (€ 1,073,562) Favourable step	€ 1,020,426 Total debts 2025: € 1,020,426 ▲ 3% vs 2024 (€ 991,291) Unfavourable step	▲ 3%
Cash	€ 38,518 Cash 2022: € 38,518 First fiscal year in the series	€ 31,717 Cash 2023: € 31,717 ▼ 18% vs 2022 (€ 38,518) Unfavourable step	€ 22,721 Cash 2024: € 22,721 ▼ 28% vs 2023 (€ 31,717) Unfavourable step	€ 89,126 Cash 2025: € 89,126 ▲ 292% vs 2024 (€ 22,721) Favourable step	▲ 292%
Land & buildings	€ 933,323 Land & buildings 2022: € 933,323 First fiscal year in the series	€ 904,205 Land & buildings 2023: € 904,205 ▼ 3% vs 2022 (€ 933,323) Unchanged	€ 863,262 Land & buildings 2024: € 863,262 ▼ 5% vs 2023 (€ 904,205) Unchanged	€ 823,763 Land & buildings 2025: € 823,763 ▼ 5% vs 2024 (€ 863,262) Unchanged	▼ 5%
Retained profit	€ 330,719 Retained profit 2022: € 330,719 First fiscal year in the series	€ 352,801 Retained profit 2023: € 352,801 ▲ 7% vs 2022 (€ 330,719) Favourable step	€ 369,689 Retained profit 2024: € 369,689 ▲ 5% vs 2023 (€ 352,801) Favourable step	€ 414,092 Retained profit 2025: € 414,092 ▲ 12% vs 2024 (€ 369,689) Favourable step	▲ 12%
Dividend	€ 87,000 Dividend 2022: € 87,000 First fiscal year in the series	€ 75,000 Dividend 2023: € 75,000 ▼ 14% vs 2022 (€ 87,000) Unchanged	€ 60,000 Dividend 2024: € 60,000 ▼ 20% vs 2023 (€ 75,000) Unchanged	€ 70,000 Dividend 2025: € 70,000 ▲ 17% vs 2024 (€ 60,000) Unchanged	▲ 17%
Bank debt	€ 948,105 Bank debt 2022: € 948,105 First fiscal year in the series	€ 887,678 Bank debt 2023: € 887,678 ▼ 6% vs 2022 (€ 948,105) Favourable step	€ 832,660 Bank debt 2024: € 832,660 ▼ 6% vs 2023 (€ 887,678) Favourable step	€ 778,638 Bank debt 2025: € 778,638 ▼ 6% vs 2024 (€ 832,660) Favourable step	▼ 6%
Balance sheet total	€ 1,546,433 Balance sheet total 2022: € 1,546,433 First fiscal year in the series	€ 1,487,500 Balance sheet total 2023: € 1,487,500 ▼ 4% vs 2022 (€ 1,546,433) Unchanged	€ 1,418,983 Balance sheet total 2024: € 1,418,983 ▼ 5% vs 2023 (€ 1,487,500) Unchanged	€ 1,489,389 Balance sheet total 2025: € 1,489,389 ▲ 5% vs 2024 (€ 1,418,983) Unchanged	▲ 5%
Employees (FTE)	1.6 Employees (FTE) 2022: 1.6 First fiscal year in the series	1.4 Employees (FTE) 2023: 1.4 ▼ 0.2 vs 2022 (1.6) Unchanged	1.4 Employees (FTE) 2024: 1.4 Unchanged (1.4) Unchanged	1.6 Employees (FTE) 2025: 1.6 ▲ 0.2 vs 2024 (1.4) Unchanged	▲ 0.2

Key figures of APOTHEEK SMETS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK SMETS?

What happened at APOTHEEK SMETS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

May 28, 2026 New annual accounts for financial year 2025: profit of € 114,404 (▲ 49% vs 2024). Source: NBB ↗
Jan 22, 2003 New establishment in Herent. KBO
Oct 22, 2002 Start of the company according to the CBE. KBO

In short

From € 88,726 profit in 2022 to € 114,404 profit in 2025.

Paid € 53,143 in corporate taxes since 2022.

Best year ever: 2025, with € 114,404 profit.

On average € 214,600 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

SOFIMAX 99%

The stake of SOFIMAX comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK SMETS

Behind APOTHEEK SMETS is Sofimax BV. The shares are held by SOFIMAX (99%).

Directors

According to the 2025 annual accounts

Sofimax BV

Director · represented by Sofie Smets

Shareholders

SOFIMAX

99%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Wilselsesteenweg 10

3020 Herent

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

SOFIMAX same network

€ 104,368 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0478.682.429

VAT number

BE 0478.682.429

Registered office

Wilselsesteenweg 10, 3020 Herent

Names & denominations

APOTHEEK SMETS

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

22 October 2002

Peppol

Active · Active since 1 Jan 2001

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK SMETS

Financials

What happened to APOTHEEK SMETS?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions